CRP and inflammatory bowel disease: Endoscopic healing (EH) is described as the ideal goal for patients with inflammatory bowel disease (IBD) in the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE)-II [3] initiative, which states that symptomatic response is the first target; symptomatic remission and normalization of C-reactive protein (CRP) are the second targets; decrease in calprotectin to an acceptable range is the third target; and EH is the final target.